Heptares Therapeutics Company
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Technology:
Others
Industry:
PharmTech
Headquarters:
Welwyn Garden City, Hertford, United Kingdom
Founded Date:
2007
Employees Number:
11-50
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Register and Claim Ownership